CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research
Retrieved on:
Monday, April 25, 2022
Nature, DNA, Adenoviridae, HKEX, COVID-19, Meningococcal disease, Research, Life, R, Multilateralism, Group, CRM197, Trial of the century, Technology, Vaccine, Company, Infection, CanSino Biologics, History, Coronavirus, Public health, MCV4, Multimedia, SSE, RNA transfection, Pharmaceutical industry
This is the first major brand refresh of CanSinoBIO since its inception in 2009.
Key Points:
- This is the first major brand refresh of CanSinoBIO since its inception in 2009.
- The blue color represents "technology" and the green color represents "life," embracing and complementing each other to depict the close relationship between technology and human life.
- Sixty-nine years later, CanSinoBIO continues to uphold the scientific spirit by committing to continuous research and development (R&D) of innovative, high-quality and accessible vaccine products to protect human life.
- Incorporated in 2009, CanSinoBIO (SSE: 688185, HKEX: 06185) commits to research, production and commercialization of innovative vaccines for China and global public health security.